Safety [hcpp]
Efficacy [qlco]
Patients [podg]
chronic dialysis [topp]
Renal [bpoc]
Dyslipidaemia [dsyn]
Universal [bodm, carb]
Hypercholesterolaemia [dsyn]
Present [qnco]
Dialysis [npop]
Patients [podg]
Dietary [food]
therapy [ftcn]
Benefit [qnco]
majority [socb]
Drug Therapy [topp]
Compared [acty]
Efficacy [qlco]
Safety [hcpp]
Simvastatin [orch, phsu]
Lipid-lowering diet [topp]
Dialysis [npop]
placebo [topp]
Plus [qlco]
Diet [food]
randomized [resa]
DOUBLE BLIND [resa]
Trial [resa]
Stratified [qlco]
Dialysis [npop]
Modality [idcn]
Patients [podg]
treated [topp]
Haemodialysis [topp]
Peritoneal Dialysis, Continuous Ambulatory [topp]
months [tmco]
serum high density lipoprotein [lbpr]
Cholesterol [bacs, strd]
mg dl [qnco]
Low density lipoprotein [aapp, bacs, lipd]
mg dl [qnco]
Triglyceride [bacs, lipd]
mg dl [qnco]
Dietary [food]
treatment [ftcn]
Phase [tmco]
Diet [food]
Plus [qlco]
placebo [topp]
RUN-IN [tmco]
Phase [tmco]
DOUBLE BLIND [resa]
treatment [ftcn]
Phase [tmco]
Seven [qnco]
Patients [podg]
Men [popg]
Women [popg]
Age-Years [tmco]
Range [qnco]
yr [tmco]
randomized [resa]
Diet [food]
Plus [qlco]
mg day [qnco]
Simvastatin [orch, phsu]
N NOS [aapp, imft]
Haemodialysis [topp]
Peritoneal Dialysis, Continuous Ambulatory [topp]
Diet [food]
Plus [qlco]
placebo [topp]
N NOS [aapp, imft]
Haemodialysis [topp]
Peritoneal Dialysis, Continuous Ambulatory [topp]
weeks [tmco]
Dose [qnco]
doubled [ftcn]
Bimonthly [tmco]
Maximum [qnco]
mg day [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
mg dl [qnco]
Patients [podg]
COMPLETED [qlco]
Trial [resa]
baseline [bodm]
weeks [tmco]
Simvastatin [orch, phsu]
mg day [qnco]
effective [qlco]
placebo [topp]
Reducing [qlco]
serum concentration [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Haemodialysis [topp]
Percentage [qnco]
Total Cholesterol [lbpr]
Simvastatin [orch, phsu]
placebo [topp]
P NOS [aapp, imft]
Cholesterol, LDL [bacs, strd]
P NOS [aapp, imft]
High Density Lipoprotein Cholesterol [bacs, lipd]
P NOS [aapp, imft]
Total Cholesterol [lbpr]
High density lipoprotein [aapp, bacs, lipd]
P NOS [aapp, imft]
Peritoneal Dialysis, Continuous Ambulatory [topp]
Total Cholesterol [lbpr]
P NOS [aapp, imft]
P NOS [aapp, imft]
High Density Lipoprotein Cholesterol [bacs, lipd]
3 6 [fndg]
P NOS [aapp, imft]
Total Cholesterol [lbpr]
High density lipoprotein [aapp, bacs, lipd]
Ratio [qnco]
P NOS [aapp, imft]
Peritoneal Dialysis, Continuous Ambulatory [topp]
Apolipoprotein A-I [aapp, bacs]
P NOS [aapp, imft]
Apo-B [aapp, bacs]
P NOS [aapp, imft]
Apo A-1 [aapp, bacs]
Apo-B [aapp, bacs]
Haemodialysis [topp]
Compared [acty]
placebo [topp]
Triglyceride level [lbtr]
Fall [fndg]
Haemodialysis [topp]
Peritoneal Dialysis, Continuous Ambulatory [topp]
High Density Lipoprotein Cholesterol [bacs, lipd]
Unchanged [fndg]
Haemodialysis [topp]
Rose [plnt]
Peritoneal Dialysis, Continuous Ambulatory [topp]
trends [tmco]
Reach [orgf]
Statistical Significance [qnco]
P NOS [aapp, imft]
Lp(a) [aapp, bacs]
Laboratory [mnob, orgt]
Adverse Experience [fndg]
Increased [qnco]
Simvastatin [orch, phsu]
treated [topp]
Patients [podg]
Compared [acty]
placebo [topp]
Simvastatin [orch, phsu]
APPEAR [qlco]
effectiveness treatment [qlco]
reduction [npop]
High density lipoprotein cholesterol level [lbpr]
Haemodialysis [topp]
Peritoneal Dialysis, Continuous Ambulatory [topp]
Patients [podg]
national [inpr]
Kidney [bpoc]
Foundation [orgt]
